Pine Labs Ltd (PINELABS) Q1 FY27 Results Analysis: PAT Surges 4x, Margin Compresses
CompoundingAI Research
Updated July 28, 2026
2 min read
Negative
Pine Labs Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 736.92 Cr (+19.65% YoY) and PAT growth of +308.56% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 28, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 736.92 Cr (+19.65% YoY) |
|---|
| PAT (Q1) | Rs. 19.57 Cr (+308.56% YoY) |
|---|
| EBITDA margin | 17.10% (-290 bps YoY) |
|---|
| EPS (Q1) | Rs. 0.17 (+240.00% YoY) |
|---|
| Market cap | Rs. 17,645.92 Cr |
|---|
| CMP | Rs. 152.94 |
|---|
Quarter Snapshot
Pine Labs Q1 FY27 revenue grew 19.65% YoY but missed the lower end of FY27 guidance of 21% due to seasonality. PAT surged 4x YoY, but Adj. EBITDA margins compressed to 17.1% (vs guided 19-20%) due to IAP mix shift and hardware costs. The OMC contract ramp and IAP growth are potential catalysts for H2 recovery, but margin pressure remains a key concern.
Key Investment Insights
Key Positives
- Revenue grew 19.65% YoY to Rs.736.92 Cr.
- PAT grew 308.56% YoY to Rs.19.57 Cr, swinging from a loss of Rs.4.84 Cr in Q1 FY26.
- IAP segment revenue grew 30.99% YoY, and international revenue grew 21% YoY to Rs.114 Cr.
- Finance costs declined 40.20% YoY due to debt reduction.
- Employee benefits expense declined 8.17% YoY, reflecting operating leverage.
- EPS (basic) increased 3.4x YoY from Rs.0.05 to Rs.0.17.
Risk Factors
- Revenue growth of 19.65% YoY fell short of management's FY27 guidance of 21-23.5%.
- Adj. EBITDA margin compressed to 17.1% from 20% YoY, below guided 19-20% steady state.
- Contribution margin declined 560 bps YoY to 72.28%, the lowest in recent trend.
- IAP contribution margin dropped sharply from 62.43% to 52.40% YoY, indicating margin pressure from mix shift.
- Transaction and related costs grew 62.93% YoY, outpacing revenue growth.
- Effective tax rate at 48.13% is very high, compressing PAT.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now